RK
Rajeev Kumar Sharma
About Rajeev Kumar Sharma
Data last updated:
Rajeev Kumar Sharma is a Director at Fee-Way Pharmaceuticals Private Limited (since 2023). The company operates in Chemicals. Fee-Way Pharmaceuticals Private Limited reported revenue of ₹2.9 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 09 Nov 2023 | 2021 | ₹2.9 Lakh (FY 2024) | Active |
Board colleagues of Rajeev Kumar Sharma
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rohit Sharma | 09395706 | Fee-Way Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajeev Kumar Sharma
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajeev Kumar Sharma
Rajeev Kumar Sharma currently holds 1 directorship: Fee-Way Pharmaceuticals Private Limited (Director, since 09 Nov 2023, revenue ₹2.9 Lakh (FY 2024)).
Rajeev Kumar Sharma was first appointed on 09 Nov 2023 as Director at Fee-Way Pharmaceuticals Private Limited.
The current boards of Rajeev Kumar Sharma's companies include Rohit Sharma (Fee-Way Pharmaceuticals Private Limited).